Early Interferon-beta Treatment for West-Nile Virus Infection

Key facts

Sponsor

Tel-Aviv Sourasky Medical Center

Intervention

Rebif 44 MCG Per 0.5 ML Prefilled Syringe(drug)

Enrollment

100 enrolled

Eligibility

18 years · All sexes

Timeline

2024 – 2025

Study locations (1)

• Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07332234
  Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies
  Spitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
• ACTIVE NOT RECRUITINGNCT06820060
  Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel Plus
  QIAGEN Gaithersburg, Inc
• ACTIVE NOT RECRUITINGPHASE2NCT06899802
  A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
  Bavarian Nordic
• RECRUITINGPHASE1, PHASE2NCT06680128
  A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
  SK Bioscience Co., Ltd.
• RECRUITINGNCT06368648
  CoMind Early Feasibility Study
  CoMind Technologies Limited
• ACTIVE NOT RECRUITINGPHASE4NCT06678373
  Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
  Liaoning Chengda Biotechnology CO., LTD
• RECRUITINGNCT07191223
  Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
  University Hospital, Strasbourg, France
• RECRUITINGNCT07251049
  Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing
  Centre Hospitalier Universitaire de la Guadeloupe

See all trials for Encephalitis →